Saline-Filled Breast Implant Labels Note 13-40% Re-operation Rate At 3 Years
This article was originally published in The Gray Sheet
Executive Summary
Informed consent labeling for saline-filled breast implants notes that 13-40% of women who receive the implants require some form of additional surgical treatment within three years.
You may also be interested in...
Inamed augments PMA filing
Supplemental data for firm's silicone gel-filled breast implants have been submitted to FDA, company announces Aug. 19. The addition responds to a January FDA non-approvable letter (1"The Gray Sheet" Jan. 12, 2004, p. 3). Inamed also has filed seven-year follow-up data on saline implants, required as a condition of May 2000 PMA approval, according to an Aug. 12 release (2"The Gray Sheet" May 15, 2000, p. 15). The data found a 9.8% deflation rate for the 876-patient augmentation cohort and 12.4% deflation for the 194-patient reconstruction cohort...
Inamed augments PMA filing
Supplemental data for firm's silicone gel-filled breast implants have been submitted to FDA, company announces Aug. 19. The addition responds to a January FDA non-approvable letter (1"The Gray Sheet" Jan. 12, 2004, p. 3). Inamed also has filed seven-year follow-up data on saline implants, required as a condition of May 2000 PMA approval, according to an Aug. 12 release (2"The Gray Sheet" May 15, 2000, p. 15). The data found a 9.8% deflation rate for the 876-patient augmentation cohort and 12.4% deflation for the 194-patient reconstruction cohort...
NCI Silicone Breast Implant Study Will Assess Connective Tissue Disease
Follow-up analyses of a 13,500-patient silicone breast implant study will evaluate the relationship of the devices to connective tissue diseases (CTD), according to a 1report submitted to Congress by the National Institutes of Health April 24